EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 236 filers reported holding EMERGENT BIOSOLUTIONS INC in Q4 2019. The put-call ratio across all filers is 4.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $336,000 | +17.1% | 6,436 | +8.4% | 0.01% | +9.1% |
Q2 2019 | $287,000 | -2.7% | 5,936 | +1.7% | 0.01% | -8.3% |
Q1 2019 | $295,000 | -14.7% | 5,836 | 0.0% | 0.01% | -25.0% |
Q4 2018 | $346,000 | -9.9% | 5,836 | 0.0% | 0.02% | +14.3% |
Q3 2018 | $384,000 | +30.2% | 5,836 | 0.0% | 0.01% | +16.7% |
Q2 2018 | $295,000 | -3.9% | 5,836 | 0.0% | 0.01% | -7.7% |
Q1 2018 | $307,000 | +28.5% | 5,836 | +13.6% | 0.01% | +30.0% |
Q4 2017 | $239,000 | +39.8% | 5,136 | +21.2% | 0.01% | +25.0% |
Q3 2017 | $171,000 | +66.0% | 4,236 | +39.3% | 0.01% | +60.0% |
Q2 2017 | $103,000 | +134.1% | 3,042 | +102.8% | 0.01% | +150.0% |
Q1 2017 | $44,000 | -53.7% | 1,500 | -48.3% | 0.00% | -66.7% |
Q4 2016 | $95,000 | +4.4% | 2,900 | 0.0% | 0.01% | 0.0% |
Q3 2016 | $91,000 | -35.0% | 2,900 | -12.1% | 0.01% | +200.0% |
Q2 2016 | $140,000 | -50.9% | 3,300 | -57.9% | 0.00% | -50.0% |
Q1 2016 | $285,000 | -10.9% | 7,840 | -2.0% | 0.00% | -20.0% |
Q4 2015 | $320,000 | – | 8,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 306,838 | $2,255,000 | 0.50% |
BOULDER HILL CAPITAL MANAGEMENT LP | 23,000 | $169,050 | 0.32% |
EMC Capital Management | 2,147 | $397 | 0.31% |
Values First Advisors, Inc. | 50,903 | $374,135 | 0.23% |
AIMZ Investment Advisors, LLC | 52,122 | $383,097 | 0.16% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 839,433 | $6,169,833 | 0.15% |
PALISADE CAPITAL MANAGEMENT, LP | 538,418 | $3,957,372 | 0.10% |
AXQ CAPITAL, LP | 10,100 | $74,235 | 0.09% |
SummerHaven Investment Management, LLC | 15,285 | $112,345 | 0.07% |
CAXTON ASSOCIATES LP | 50,265 | $369,448 | 0.06% |